Unanswered questions following reports of secondary malignancies after CAR-T cell therapy
Bruce L. Levine, Marcelo C. Pasquini, John E. Connolly, David L. Porter, Michael P. Gustafson, Jaap Jan Boelens, Edwin M. Horwitz, Stephan A. Grupp, Marcela V. Maus, Frederick L. Locke, Fabio Ciceri, Annalisa Ruggeri, John A. Snowden, Helen E. Heslop, Crystal L. Mackall, Carl H. June, Anna M. Sureda, Miguel‐Angel Perales
Topics & Concepts
CAR T-cell therapyMedicineCancer therapyCell therapyOncologyCancerCellInternal medicineImmunotherapyBiologyChimeric antigen receptorGeneticsCAR-T cell therapy researchVirus-based gene therapy researchBiomedical Ethics and Regulation